Back

Pro-Cognitive Effects of IgM Isotype Anti-NMDAR1 Autoantibodies in Mice

DeWit, J. M.; Tebyanian, T.; Unapanta, A.; Vaughn, M. N.; Powell, S. B.; Risbrough, V. B.; Zhou, X.

2026-04-28 neuroscience
10.64898/2026.04.24.720689 bioRxiv
Show abstract

Natural anti-NMDAR1 autoantibodies are present at varying levels in the general human population, but their effects on cognitive function remain unclear. Recent human studies reported significant associations between higher blood levels of natural anti-NMDAR1 autoantibodies and potential neuroprotective outcomes in Alzheimers disease, traumatic brain injury-associated depression and PTSD symptoms, and schizophrenia. However, whether these natural autoantibodies play a causal role in emotional and cognitive function has not been investigated. Since natural autoantibodies in human blood are predominantly of the IgM isotype, we immunized Aicda mutant mice to produce only IgM isotype anti-NMDAR1 autoantibodies without IgG and IgA isotypes. Mice were tested for sensorimotor gating and conditioned fear and extinction, cross species measures of information processing and emotional memory, respectively. Mice with higher levels of IgM anti-NMDAR1 autoantibodies exhibited significantly increased sensorimotor gating and improved fear extinction recall compared with mice with baseline levels of these autoantibodies. These findings indicate that IgM anti-NMDAR1 autoantibodies are pro-cognitive, unlike previous reports of poor cognition associated with IgG anti-NMDAR1 autoantibodies. Together, these studies suggest that IgM may hold therapeutic potential for a range of neurodegenerative, neurological, and psychiatric disorders.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Brain, Behavior, and Immunity
105 papers in training set
Top 0.1%
18.2%
2
Neurobiology of Disease
134 papers in training set
Top 0.2%
14.3%
3
Molecular Psychiatry
242 papers in training set
Top 0.2%
10.1%
4
Translational Psychiatry
219 papers in training set
Top 1%
4.3%
5
Alzheimer's & Dementia
143 papers in training set
Top 1%
3.6%
50% of probability mass above
6
Brain
154 papers in training set
Top 2%
3.6%
7
Brain, Behavior, & Immunity - Health
27 papers in training set
Top 0.1%
3.6%
8
Scientific Reports
3102 papers in training set
Top 41%
3.1%
9
PLOS ONE
4510 papers in training set
Top 53%
1.7%
10
Journal of Neuroinflammation
50 papers in training set
Top 0.4%
1.7%
11
Communications Biology
886 papers in training set
Top 10%
1.7%
12
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.7%
13
ACS Chemical Neuroscience
60 papers in training set
Top 1%
1.7%
14
iScience
1063 papers in training set
Top 18%
1.5%
15
Molecular Neurodegeneration
49 papers in training set
Top 0.6%
1.3%
16
Neurobiology of Aging
95 papers in training set
Top 2%
0.9%
17
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.9%
18
Biological Psychiatry Global Open Science
54 papers in training set
Top 1%
0.9%
19
Cell Reports
1338 papers in training set
Top 31%
0.9%
20
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.2%
0.8%
21
Journal of Neurology
26 papers in training set
Top 1%
0.8%
22
Neuropsychopharmacology
134 papers in training set
Top 3%
0.7%
23
The Journal of Neuroscience
928 papers in training set
Top 8%
0.7%
24
eneuro
389 papers in training set
Top 9%
0.7%
25
Frontiers in Cellular Neuroscience
79 papers in training set
Top 1%
0.7%
26
Annals of Neurology
57 papers in training set
Top 2%
0.7%
27
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.7%
28
Journal of Alzheimer’s Disease
39 papers in training set
Top 1%
0.7%
29
Acta Neuropathologica
51 papers in training set
Top 1%
0.6%
30
Nature Aging
51 papers in training set
Top 2%
0.6%